期刊文献+

γ-氨基丁酸改善2,4,6-三硝基苯磺酸-乙醇诱导的结肠炎肠黏膜屏障损伤作用 被引量:5

Improvement of Gamma-aminobutyric Acid on Intestinal Mucosalbarrier Injury of Colitis Induced by 2,4,6-trinitrobenzene Sulfonic Acid and Alcohol
下载PDF
导出
摘要 目的探讨γ-氨基丁酸(GABA)改善2,4,6-三硝基苯磺酸(TNBS)-乙醇诱导的结肠炎肠黏膜屏障损伤作用。方法 SD大鼠随机分为正常对照组,TNBS-乙醇溶液模型对照组,造模后GABA 200,100,50 mg·kg-1治疗组。造模后连续14 d,观察记录体质量变化、疾病活动指数(DAI);造模第15天,每组取5只,进行伊文思蓝染色。大鼠取结肠,组织学损伤评分,同时量取结肠长度、称重。通过WB法观察实验性结肠炎各组大鼠肠黏膜屏障连接蛋白及LC3表达情况。结果 GABA增加Caco-2细胞单层模型细胞电阻,减少FD4的渗透,降低单层模型通透性。GABA改善实验性结肠炎引起的体质量下降,增加DAI,降低结肠指数。另外,GABA降低实验性结肠炎大鼠伊文思蓝渗透性及结肠病理变化,显著提高大鼠Occludin、Claudin-4、ZO-1蛋白表达。实验性结肠炎大鼠肠细胞出现过度自噬,GABA抑制过度自噬。结论GABA通过改善肠黏膜屏障损伤,缓解TNBS-乙醇溶液诱导的实验性结肠炎,故改善肠黏膜屏障损伤可能是治疗炎症性肠病(IBD)的新方法。 Objective To investigate the protective effects of GABA against experimental inflammatory bowel disease( IBD) by enhanced intestinal barrier function and explore its underlying mechanisms. Methods Forty SD rats were randomly divided into normal control group,TNBS-alcohol model control group,200,100,50 mg · kg^-1 GABA treatment group. After modeling for 14 days,the changes of body weight and disease activity indexes( DAI) were observed. On the 15 th day after modeling,5 rats in each group were subjected to Evans blue staining. For the remaining rats,colon was collected and evaluated with histological injury score; the length and weight of the colon was determined.The intestinal mucosal barrier connexin and LC3 expression in rats with experimental colitis were observed by WB method. Results The cell resistance of Caco-2 monolayer models was increased and the infiltration of FD4 and the monolayer permeability was reduced by GABA.GABA also improved body mass,increased DAI,and lowered colon index. In addition,GABA decreased the Evans blue permeability and pathological changes in rats with experimental colitis,and significantly increased the Occludin,Claudin-4 and ZO-1 protein expression in the rats.Intestinal autophagy appeared in experimental colitis rats,GABA inhibited excessive autophagy. Conclusion GABA could relieve TNBS-ethanol-induced experimental colitis,and the mechanism might be related to the improvement of intestinal mucosal barrier injury.
作者 蒋廷媛 岳源 李芳华 JIANG Tingyuan;YUE Yuan;LI Fanghua(Department of Pharmacy,the Second People's Hospital of Yichang,Yichang 443000,China;School of Pharmaceutical Sciences,Wuhan University,Wuhan 430071,China)
出处 《医药导报》 CAS 北大核心 2018年第8期931-938,共8页 Herald of Medicine
基金 国家自然科学基金资助项目(81273523)
关键词 Γ-氨基丁酸 2 4 6-三硝基苯磺酸 炎症性肠病 肠黏膜屏障 Gamma-aminobutyric acid 2,4,6-trinitrobenzene sulfonic acid Inflammatory bowel disease Intestinal mucosal barrier
  • 相关文献

参考文献3

二级参考文献150

  • 1Wu HG,Zhou LB,Pan YY,Huang C,Chen HP,Shi Z,Hua XG.Study of the mechanisms of acupuncture and moxibustion treatmentfor ulcerative colitis ratsinview of the gene expression of cytokines[J].World Journal of Gastroenterology,1999,5(6):515-517. 被引量:45
  • 2马向明,王新中.Acupuncture Treatment for 76 Cases of Ulcerative Colitis[J].Journal of Traditional Chinese Medicine,2005,25(4):264-265. 被引量:5
  • 3Aggarwal S,Pittenger MF.Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood,2005.
  • 4Tang Q;Henriksen KJ;Bi M.In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes,2004.
  • 5Zuk PA.Human adipose tissue is a source of multipotent stem cells,2002.
  • 6Beyth S;Borovsky Z;Mevorach D.Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness,2005(05).
  • 7Miller DG;Adam MA;Miller AD.Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection,1990.
  • 8Stilwell JL;Samulski RJ.Adeno-associated virus vectors for therapeutic gene transfer,2003.
  • 9HORI S;NOMURA T;SAKAGUCHI S.Control of regulatory T cell development by the transcription factor Foxp3,2003.
  • 10Roncarolo MG;Battaglia M.Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans,2007.

共引文献42

同被引文献56

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部